Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Donfrancesco, Chiara ^a   Palleschi, Simonetta ^a   Palmieri, Luigi ^a   Rossi, Barbara ^a   Lo Noce, Cinzia ^a   Pannozzo, Fabio ^b   Spoto, Belinda ^c   Tripepi, Giovanni ^c   Zoccali, Carmine ^b   Giampaoli, Simona ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Endocrinology Unit   (Italy)

^c Epidemiologia Clinica e Patofisiologia delle Malattie Renali e dell'Ipertensione Arteriosa   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84885744580     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078475     Document Type: Article

References (38)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, et al. (2007) Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int; 72: 247-259. doi:10.1038/sj.ki.5002343. PubMed: 17568785.
2. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifi cation, and stratification. Am J Kidney Dis 39: S1-266. doi:10.1053/ajkd.2002.30571. PubMed: 11904577.
3. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH, (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663. doi:10.1001/archinte.164.6.659. PubMed: 15037495.
4. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, et al. (2005) Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16: 3728-3735. doi:10.1681/ASN.2005040384. PubMed: 16251239.
5. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, et al. (2012) European guidelines on cardiovascular disease prevention in clinical practice (Version 2012). Eur Heart J 33: 1635-1701. doi:10.1093/eurheartj/ehs092. PubMed: 22555213.
6. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, et al. (2007) Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study. Arch Intern Med 167: 2490-2496. doi:10.1001/archinte.167.22.2490. PubMed: 18071172.
7. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, et al. (2010) Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 341: c4986. doi:10.1136/bmj.c4986. PubMed: 20884698.
8. van der Velde M, Bakker SJ, de Jong PE, Gansevoort RT, (2010) Influence of Age and Measure of eGFR on the Association between Renal Function and Cardiovascular Events. Clin J Am Soc Nephrol 5: 2053-2059. doi:10.2215/CJN.08851209. PubMed: 20705964.
9. Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081. doi:10.1016/S0140-6736(10)60674-5. PubMed: 20483451.
10. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J, (2010) Risk implications of the new CKD-EPI equation as compared to the MDRD Study equation for estimated glomerular filtration rate: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 55: 648-659. doi:10.1053/j.ajkd.2009.12.016. PubMed: 20189275.
11. Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V, (2007) Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLOS Med 4: e270. doi:10.1371/journal.pmed.0040270. PubMed: 17803353.
12. Chang A, Kramer H, (2011) Should eGFR and Albuminuria be added to the Framingham risk score? Chronic Kidney Disease and Cardiovascular risk prediction. Nephron Clin Pract 119: c171-c178. doi:10.1159/000325669. PubMed: 21811078.
13. Ito H, Pacold IV, Durazo-Arvizu R, Liu K, Shilipak MG, et al. (2011) The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis. Am J Epidemiol 174: 949-957. doi:10.1093/aje/kwr185. PubMed: 21880578.
14. Glassock RJ, Winearls C, (2008) An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 23: 1117-1121. PubMed: 18359870.
15. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Eur. Heart: pp. J 24:1601-10.
16. Menotti A, Lanti M, Puddu PE, Kromhout D, (2000) Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 84: 238-244. doi:10.1136/heart.84.3.238. PubMed: 10956281.
17. Giampaoli S, Poce A, Sciarra F, Lo Noce C, Dima F, et al. (1997) Change in cardiovascular risk factors during 10-year community intervention program. Acta Cardiol 52: 411-422. PubMed: 9428939.
18. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, et al. for the CUORE Project Research Group (2005) Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 34: 413-421. doi:10.1093/ije/dyh405. PubMed: 15659467.
19. World Health Organization, Office of Cardiovascular Diseases, WHO MONICA Project (1999) MONICA Manual [online resource]. Available: http://www.ktl.fi/publications/monica/manual/index.htm. URN; NBN:fi-fe19981146. Accessed 9 September 2013.
20. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, et al. (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52: 5-18. doi:10.1373/clinchem.2005.0525144. PubMed: 16332993.
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612. doi:10.7326/0003-4819-150-9-200905050-00006. PubMed: 19414839.
22. Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Ferrario M, et al. (2006) Favorable cardiovascular risk profile (low risk) and 10-year stroke incidence in women and men: findings on twelve Italian population samples. Am J Epidemiol 163: 893-902. doi:10.1093/aje/kwj110. PubMed: 16554350.
23. Palmieri L, Donfrancesco C, Giampaoli S, Trojani M, Panico S, et al. (2006) Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil 13: 562-570. doi:10.1097/01.hjr.0000221866.27039.4b. PubMed: 16874146.
24. World Health Organization (1977) International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Geneva, Switzerland: World Health Organization.
25. Palmieri L, Panico S, Vannuzzo D, Ferrario M, Pilotto L, et al. (2004) La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del progetto CUORE. Ann Ist Super Sanità [Annals of the National Health Institute] 40: 393-399.
26. Giampaoli S, Palmieri L, Donfrancesco C, Panico S, Vannuzzo D, et al. (2007) Cardiovascular risk assessment in Italy: the CUORE project risk score and risk chart. It J Public Health 5: 102-109.
27. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, et al. (2008) Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes. N Engl J Med 358: 2107-2116. doi:10.1056/NEJMoa0707064. PubMed: 18480203.
28. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, et al. (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307: 1941-1951. doi:10.1001/jama.2012.3954. PubMed: 22570462.
29. Cirillo M, Lombardi C, Mele AA, Marcarelli F, Bilancio G, (2012) A population-based approach for the definition of chronic kidney disease: the CKD Prognosis Consortium. J Nephrol 25: 7-12. doi:10.5301/jn.5000045. PubMed: 22038337.
30. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, et al. for the Chronic Kidney Disease Prognosis Consortium (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 380: 1-13. doi:10.1016/S0140-6736(11)61925-9. PubMed: 22770441.
31. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, et al. (2000) Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 133: 585-591. doi:10.7326/0003-4819-133-8-200010170-00008. PubMed: 11033585.
32. Nitsch D, Felber Dietrich D, von Eckardstein A, Gaspoz JM, Downs SH, et al. (2006) Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: Results of the Swiss SAPALDIA study. Nephrol Dial Transplant 21: 935-944. PubMed: 16390852.
33. Ishizaka N, Ishizaka Y, Toda E, Shimomura H, Koike K, et al. (2008) Association between cigarette smoking and chronic kidney disease in Japanese men. Hypertens Res 31: 485--492. doi:10.1291/hypres.31.485. PubMed: 18497468.
34. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, et al. (2011) Estimated GFR Associates with Cardiovascular Risk Factors Independently of Measured GFR. J Am Soc Nephrol 22: 927-937. doi:10.1681/ASN.2010050479. PubMed: 21454717.
35. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, et al. (2000) Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11: 1882-1888. PubMed: 11004219.
36. Gislefoss RE, Grimsrud TK, Mørkrid L, (2008) Long-term stability of serum components in the Janus Serum Bank. Scand_J Clin Lab Invest 68: 402-409. doi:10.1080/00365510701809235. PubMed: 18752145.
37. Greenberg N, Roberts WL, Bachmann LM, Wright EC, Dalton RN, et al. (2012) Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin_Chem 58: 391-401. doi:10.1373/clinchem.2011.172288. PubMed: 22166253.
38. Donfrancesco C, Palmieri L, Vanuzzo D, Panico S, Ferrario MM, et al. on behalf of Progetto CUORE and Osservatorio Epidemiologico Cardiovascolare research groups (2010) Il Progetto CUORE: analisi preliminari per l'aggiornamento delle carte del rischio e del punteggio individuale. G Ital Cardiol 11 (Suppl 3) (5):: 20S-24S.